Stay updated on Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page.

Latest updates to the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page
- Check5 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed from the page history.SummaryDifference0.1%

- Check12 days agoChange DetectedRevision v3.4.3 has been added and revision v3.4.2 has been removed from the history.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe study history shows an added site revision entry (v3.4.2) and the removal of an older funding/operating status notice (v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check47 days agoChange DetectedThe page adds a site-wide funding notice and records a new revision (v3.4.1) with a Study Status entry, while removing the prior revision (v3.4.0).SummaryDifference0.7%

- Check54 days agoChange DetectedUI changes on the Study Record History page introduce a glossary, color-coded highlights (green for additions, red for deletions), and the revision label Revision: v3.4.0, while removing the No FEAR Act data note and the older Revision: v3.3.4 label.SummaryDifference0.6%

- Check68 days agoChange DetectedThe page history shows a new revision v3.3.4 has been added and the previous revision v3.3.3 is removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page.